SHREE GANESH REMEDIES LIMITEDSS

SHREE GANESH REMEDIES LIMITED

668,75INRG
−9,10−1,34%
Kapanışta Oca 3, 10:50 UTC
INR
İşlem yok
Süper-grafiklerde görün

SGRL temelleri

Gelir, giderler, kâr ve zarar dahil olmak üzere SHREE GANESH REMEDIES LIMITED mali tabloları

SGRL'nin son çeyrekteki toplam geliri 323.32 M INR ve önceki çeyreğe göre 30.48% daha yüksek. Q2 24 döneminin net geliri 64.06 M INR'dur.

Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0,00‬
‪‪100,00 M‬‬
‪‪200,00 M‬‬
‪‪300,00 M‬‬
‪‪400,00 M‬‬
Toplam Gelir
Brüt Kar
Faaliyet gelirleri
Vergi öncesi gelir
Net gelir
Döviz: INR
Q1 '20
Haz 2020
Q2 '20
Eyl 2020
Q3 '20
Ara 2020
Q4 '20
Mar 2021
Q1 '21
Haz 2021
Q2 '21
Eyl 2021
Q3 '21
Ara 2021
Q4 '21
Mar 2022
Q1 '22
Haz 2022
Q2 '22
Eyl 2022
Q3 '22
Ara 2022
Q4 '22
Mar 2023
Q1 '23
Haz 2023
Q2 '23
Eyl 2023
Q3 '23
Ara 2023
Q4 '23
Mar 2024
Q1 '24
Haz 2024
Q2 '24
Eyl 2024
TTM
Toplam GelirYY büyüme
‪‪219,94 M‬‬
+4,10%
‪‪293,27 M‬‬
+42,65%
‪‪267,20 M‬‬
+51,48%
‪‪334,15 M‬‬
+57,18%
‪‪279,74 M‬‬
+27,18%
‪‪373,32 M‬‬
+27,29%
‪‪247,80 M‬‬
−7,26%
‪‪323,32 M‬‬
−3,24%
‪‪1,22 B‬‬
‪‪−145,31 M‬‬
‪‪−180,49 M‬‬
‪‪−165,24 M‬‬
‪‪−213,47 M‬‬
‪‪−163,46 M‬‬
‪‪−177,37 M‬‬
‪‪−127,61 M‬‬
‪‪−180,80 M‬‬
‪‪−649,23 M‬‬
Brüt KarYY büyüme
‪‪74,64 M‬‬
−7,92%
‪‪112,78 M‬‬
+53,59%
‪‪101,95 M‬‬
+56,60%
‪‪120,69 M‬‬
+46,63%
‪‪116,27 M‬‬
+55,78%
‪‪195,95 M‬‬
+73,74%
‪‪120,19 M‬‬
+17,89%
‪‪142,52 M‬‬
+18,09%
‪‪574,94 M‬‬
‪‪−30,68 M‬‬
‪‪−40,43 M‬‬
‪‪−44,45 M‬‬
‪‪−42,52 M‬‬
‪‪−53,00 M‬‬
‪‪−45,20 M‬‬
‪‪−59,14 M‬‬
‪‪−53,66 M‬‬
‪‪−211,00 M‬‬
‪‪43,96 M‬‬
−8,20%
‪‪72,35 M‬‬
+77,91%
‪‪57,51 M‬‬
+67,74%
‪‪78,16 M‬‬
+76,68%
‪‪63,27 M‬‬
+43,93%
‪‪150,75 M‬‬
+108,36%
‪‪61,06 M‬‬
+6,18%
‪‪88,86 M‬‬
+13,69%
‪‪363,94 M‬‬
‪‪13,71 M‬‬
‪‪3,97 M‬‬
‪‪7,23 M‬‬
‪‪7,92 M‬‬
‪‪10,94 M‬‬
‪‪11,68 M‬‬
‪‪2,26 M‬‬
‪‪−2,50 M‬‬
‪‪22,38 M‬‬
‪‪57,67 M‬‬
+2,35%
‪‪76,32 M‬‬
+47,11%
‪‪64,70 M‬‬
+66,31%
‪‪86,08 M‬‬
+62,58%
‪‪74,21 M‬‬
+28,69%
‪‪162,42 M‬‬
+112,80%
‪‪63,32 M‬‬
−2,14%
‪‪86,36 M‬‬
+0,32%
‪‪386,31 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−14,17 M‬‬
‪‪−17,65 M‬‬
‪‪−17,19 M‬‬
‪‪−20,55 M‬‬
‪‪−26,20 M‬‬
‪‪−36,59 M‬‬
‪‪−16,83 M‬‬
‪‪−22,30 M‬‬
‪‪−101,92 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪43,50 M‬‬
‪‪58,67 M‬‬
‪‪47,51 M‬‬
‪‪65,54 M‬‬
‪‪48,01 M‬‬
‪‪125,83 M‬‬
‪‪46,49 M‬‬
‪‪64,06 M‬‬
‪‪284,39 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Net gelirYY büyüme
‪‪43,50 M‬‬
+3,52%
‪‪58,67 M‬‬
+52,81%
‪‪47,51 M‬‬
+65,71%
‪‪65,54 M‬‬
+66,49%
‪‪48,01 M‬‬
+10,38%
‪‪125,83 M‬‬
+114,48%
‪‪46,49 M‬‬
−2,16%
‪‪64,06 M‬‬
−2,26%
‪‪284,39 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪43,50 M‬‬
‪‪58,67 M‬‬
‪‪47,51 M‬‬
‪‪65,54 M‬‬
‪‪48,01 M‬‬
‪‪125,83 M‬‬
‪‪46,49 M‬‬
‪‪64,06 M‬‬
‪‪284,39 M‬‬
‪3,60‬
+3,50%
‪4,78‬
+50,56%
‪3,86‬
+62,81%
‪5,32‬
+63,56%
‪3,74‬
+3,90%
‪9,79‬
+104,91%
‪3,62‬
−6,22%
‪4,99‬
−6,35%
‪22,14‬
‪3,60‬
+3,50%
‪4,78‬
+50,56%
‪3,86‬
+62,81%
‪5,32‬
+63,56%
‪3,74‬
+3,90%
‪9,79‬
+104,91%
‪3,62‬
−6,22%
‪4,99‬
−6,35%
‪22,14‬
‪‪12,09 M‬‬
‪‪12,27 M‬‬
‪‪12,31 M‬‬
‪‪12,31 M‬‬
‪‪12,85 M‬‬
‪‪12,85 M‬‬
‪‪12,84 M‬‬
‪‪12,85 M‬‬
‪‪12,09 M‬‬
‪‪12,27 M‬‬
‪‪12,31 M‬‬
‪‪12,31 M‬‬
‪‪12,85 M‬‬
‪‪12,85 M‬‬
‪‪12,84 M‬‬
‪‪12,85 M‬‬
FAVÖKYY büyüme
‪‪53,71 M‬‬
−7,03%
‪‪82,63 M‬‬
+77,82%
‪‪67,72 M‬‬
+59,43%
‪‪92,25 M‬‬
+73,20%
‪‪82,08 M‬‬
+52,83%
‪‪169,31 M‬‬
+104,91%
‪‪81,24 M‬‬
+19,96%
‪‪113,10 M‬‬
+22,60%
‪‪445,74 M‬‬
FVÖKYY büyüme
‪‪43,96 M‬‬
−8,20%
‪‪72,35 M‬‬
+77,91%
‪‪57,51 M‬‬
+67,74%
‪‪78,16 M‬‬
+76,68%
‪‪63,27 M‬‬
+43,93%
‪‪150,75 M‬‬
+108,36%
‪‪61,06 M‬‬
+6,18%
‪‪88,86 M‬‬
+13,69%
‪‪363,94 M‬‬
‪‪−175,98 M‬‬
‪‪−220,92 M‬‬
‪‪−209,69 M‬‬
‪‪−255,99 M‬‬
‪‪−216,46 M‬‬
‪‪−222,57 M‬‬
‪‪−186,74 M‬‬
‪‪−234,46 M‬‬
‪‪−860,23 M‬‬